Rchr
J-GLOBAL ID:202201019795080337   Update date: May. 24, 2024

Gonda Masakazu

Gonda Masakazu
Affiliation and department:
Papers (21):
  • Toshiharu Morikawa, Taku Naiki, Yosuke Sugiyama, Aya Naiki-Ito, Takashi Nagai, Toshiki Etani, Keitaro Iida, Teruki Isobe, Yusuke Noda, Nobuhiko Shimizu, et al. C-Reactive Protein Is a Potential Prognostic Marker in Patient with Advanced or Metastatic Urothelial Carcinoma Treated with Enfortumab Vedotin: A Multi-Center Retrospective Study. Cancers. 2024. 16. 9
  • Teruki Isobe, Noriyasu Kawai, Maria Aoki, Toshiharu Morikawa, Masakazu Gonda, Nami Tomiyama, Takashi Nagai, Keitaro Iida, Toshiki Etani, Taku Naiki, et al. Late relapsing testicle cancer identified with isochromosome 12p (i12p) fluorescence in situ hybridization (FISH) analysis. Pathology international. 2024. 74. 3. 160-162
  • Keitaro Iida, Taku Naiki, Toshiki Etani, Takashi Nagai, Yosuke Sugiyama, Teruki Isobe, Maria Aoki, Satoshi Nozaki, Yusuke Noda, Nobuhiko Shimizu, et al. Proton pump inhibitors and potassium competitive acid blockers decrease pembrolizumab efficacy in patients with metastatic urothelial carcinoma. Scientific reports. 2024. 14. 1. 2520-2520
  • Toshiharu Morikawa, Shoichiro Iwatsuki, Aya Naiki-Ito, Masakazu Gonda, Kazumi Taguchi, Taku Naiki, Shuzo Hamamoto, Atsushi Okada, Takahiro Yasui. Urothelial carcinoma occurring in a defunctionalized bladder after urinary diversion due to the bladder exstrophy-epispadias complex. IJU Case Reports. 2023. 7. 2. 101-104
  • 磯部 輝紀, 内木 拓, 杉山 洋介, 恵谷 俊紀, 清水 伸彦, 権田 将一, 青木 マリア, 森川 敏治, 安藤 亮介, 岡田 淳, et al. 転移性尿路上皮癌に対するアベルマブ治療成績の解析. 日本癌治療学会学術集会抄録集. 2023. 61回. O39-3
more...
MISC (3):
  • 清水伸彦, 内木拓, 鬼頭拓未, 青木マリア, 坂田卓弥, 森川敏治, 権田将一, 水野健太郎, 安井孝周. 非筋層浸潤性膀胱癌の光力学診断における経口5-アミノレブリン酸誘発性低血圧の検討. 日本癌治療学会学術集会(Web). 2023. 61st
  • 内木拓, 杉山洋介, 森川敏治, 磯部輝紀, 清水伸彦, 野田祐介, 永井隆, 惠谷俊紀, 青木マリア, 権田将一, et al. 転移性尿路上皮癌に対する3次治療施行症例の後方視的解析. 日本泌尿器科学会中部総会プログラム・抄録集. 2023. 73rd
  • 青木マリア, 内木拓, 森川敏治, 磯部輝紀, 権田将一, 清水伸彦, 野田祐介, 永井隆, 阪野里花, 恵谷俊紀, et al. Maintenance of skeletal muscle in receiving neoadjuvant chemotherapy improves the prognosis for patients with muscle invasive bladder cancer. 日本泌尿器科学会総会(Web). 2023. 110th
※ Researcher’s information displayed in J-GLOBAL is based on the information registered in researchmap. For details, see here.

Return to Previous Page